Introduction:Vajikarana is one of the eight specialities of Ashtang Ayurveda dealing with the management of pathophysiology of spermatogenesis and healthy sexual potentiation. This aphrodisiac therapy is advocated for various sexual and reproductive disease i.e., Klaibya or Erectile dysfunctions, Bandhyatva or Infertility, Shukraghata Vata or azospermia and premature ejaculation. Vrishya, a synonym of Vajikara, is the technical term indicating spermatogenic and aphrodisiac effect of a dravya (foods, herbs, spices and Medicinal plants) including audio-visual, socio-religious effects/ sexual behaviour factors/ constants). Currently, the importance of this branch has increased manifold, as more and more people are reporting to clinics with various disorders related to seminal parameters and sexual dysfunction. Material and Methods: Various drugs mentioned under these therapies were searched including scientific data pertaining to their efficacy and probable mode of action. The search was limited to Ayurveda classics, books and published works from pubmed as well as non-pubmed indexed journals including google scholar database. The present review is mainly focussed on brihatryi (Charaka Samhita, Sushruta Samhita and Ashtang) for elaborate understanding of the concept of Vrishya and Vajikarana. The texts Sarangdhar Samhita and Bhavprakash Nighantu were searched for the drugs indicated as vrishya and vajikarana properties. Results: Analyses of the textual data revealed that Vrishya dravyas act as Vajikara also, but all Vajikara dravyas do not possess Vrishya property. This appears due to predominance of stimulant action on Sukravaha Samsthana in Vajikara dravyas while Vrishya has mainly quantitative and qualitative effect on Sukra. These drugs also act on higher centres of the brain which helps to alleviate anxiety associated with sexual performance as revealed by the published scientific data. Aphrodiasics also modulate the level of the pituitary hormones FSH and LH. The drugs possessing these properties have been tabulated in the text. Conclusion: Vajikarana is the therapy while Vrishya is the property (Karma) of the drug. Vrishya drugs are successful in treating conditions of reproductive disorders and sexual performance and they have an effect on pituitary-gonadal axis. Investigations in validation of these drugs will go a long way in management of infertility.
Day to day stress at work, various physical, biological, chemical and socio-economic factors contribute to a decline in concentration, motility and in the percentage of morphologically normal spermatozoa in fertile men. Ayurveda has several effective remedies which may act as a boon for seminal disorders. Vanga Bhasma (calcined tin) is one of the most popular drugs, used as Vrishya and to potentiate sexual vigour. It has been acclaimed to be efficacious in sukra dosa, swapanmeha and also prevents sukrakshaya. The present study was undertaken to evaluate the efficacy of Vanga Bhasma as Vrishya on the basis of seminal parameters, sexual dysfunction, and quality of sexual life. The study was conducted on 30 male subjects. The results were assessed in terms of seminal parameters, Questionnaire on Quality of Sexual Life and Symptomatic relief on the basis of scoring system. Statistically significant improvement (p < 0.01) was observed on total sperm count and semen volume. Highly significant improvement, with p < 0.001 was observed on abnormal sperm forms and sperm motility. In terms of subjective parameters also, highly significant improvement, with p < 0.001 was observed in sexual desire, rigidity, ejaculation, erection and orgasm. The study revealed that Vanga Bhasma can be used as a Vrishya drug.
Background:Vaikrānta has very important place in Rasa śāstra and is placed under Mahārasa and Upratna group. It has been mentioned that vaikrānta can be used in the place of diamond, which is a very precious stone and whose use is beyond the limit of the common man. Vaikrānta possesses pharmacological and therapeutic properties similar to diamond, but still very few researchers have worked on it.Aims and Objectives:The main aim of the present study is to analyze vaikrānta bhasma by employing various organoleptic methods mentioned in Ayurvedic science along with analysis as per tools available today.Settings and Design:In the present study, vaikrānta bhasma was prepared according to method mentioned in Rasa Ratna Samuccaya. Final product is prepared according to classical parameters described in Ayurvedic science.Materials and Methods:Ayurvedic scholars have described various parameters for the qualitative evaluation of vaikrānta bhasma, but all those are subjective in nature and cannot be evaluated numerically for reproducibility of the result. With this in mind, in the present study, tests as per Ayurvedic science and analytical parameters such as scanning electron microscopy, energy dispersive X-ray analysis, Fourier transform infrared spectrometry and inductively coupled plasma spectrometry were adopted to analyze the final product.Results and Conclusions:Data suggests that vaikrānta bhasma is a multi-mineral compound, which contains iron and silica as major constituents and others are present as trace elements. The data obtained in this study suggest that quality specifications for vaikrānta bhasma can be developed using tests described in Ayurvedic science along with analytical tools available today.
Chronic Obstructive Pulmonary Disease (COPD) threatens as emerging public health crisis. The two major drivers for this are the ageing of the world's population and the impressive, if deplorable, success of the multinational tobacco companies at forcing open world markets. One of the most striking aspect of COPD is that it is heterogenous. There are many different presentations with differing intensities of symptoms and even differing responses to the medication. Sorting out, what accounts for this phenomenon and how treatments can be best individualised, is of concern to both basic and clinical scientists. COPD is a leading cause of morbidity and mortality worldwide and results in a substantial economic and social burden to society. It is the sixth most common cause of death worldwide and expected to rise to third position by 2020. Several national and international agencies like WHO, GOLD, ATS, ERS etc. are working in a direction of finding some solution of this wicked problem. In Ayurvedic texts Shwasa Roga has been described having symptomatology close to COPD. A study was carried out in P.G.Deptt. of Kayachikitsa in R.G.G.P.G.Ayu.College Paprola, H. P. where the role and efficacy of two Ayurvedic formulations -Vasadi Syrup and Shwasaghna Dhuma was evaluated on 30 patients of COPD selected on the basis of fixed inclusion and exclusion criteria in two different groups. In both the groups drugs provided significant results based on subjective symptomatological criteria and objective spirometric criteria.
Osteoporosis is an alarming issue in the society today. It is continuously increasing its signicance with increasing elderly population and is affecting both the sexes at different degrees. It is characterized by low bone mass with microarchitectural deterioration of bone leading to enhanced bone fragility, thus increasing the susceptibility to fracture. Taking into account the references available in various Ayurvedic classics it can be correlated to Asthikshaya. Asthikshaya occurs due to decrease in strength of Asthi Dhatu chiey due to Kala, Swabhava and Vata Prakopa. International Osteoporosis Foundation estimated that the annual direct cost of treating osteoporotic fractures has increased grossly. In India the general population is not much aware about the hazardous complications of osteoporosis. The modern pharmacological treatment is long and beyond the nancial reach of common people. Therefore the best way to deal with it is to prevent this as early as possible. To achieve this aim a clinical study was conducted to evaluate the effect of an Ayurvedic Formulation known as Eleg Fem capsules (Asthishrinkhalaadi Yoga) in osteoporotic patients. In the clinical trial 30 patients above the age of 40 years with low BMD T-Score were registered from OPD and IPD of Kayachikitsa department of Rajiv Gandhi Govt. Post Graduate Ayurvedic College and Hospital Paprola, Kangra. Out of 30 patients, 27 completed the trial and 3 patients were drop out. Criteria of assessment of patients was change in bone mineral density (BMD T- Score) and change in the score of Quality of Life Index Questionnaire for Osteoporosis (QUALEFFO-41). All the registered patients were given the formulation for 6 weeks. Improvement was observed with statistically signicant results on mean BMD TScore and moderately signicant result on Quality of Life Index scoring. The study revealed that the Eleg Fem capsules (Asthishrinkhalaadi Yoga) is a safe and effective therapy in the Osteoporotic patients.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.